Messages from the Malaysian Diabetes Registries on Diabetes Care in Malaysian public healthcare facilities

Prim Care Diabetes. 2016 Oct;10(5):383-6. doi: 10.1016/j.pcd.2016.07.003. Epub 2016 Jul 25.

Abstract

A persistent and increasing prevalence of diagnosed and undiagnosed diabetes mellitus has recently been reported in the National Health and Morbidity Survey 2015. This commentary recapitulates the relevant and valuable lessons in the Malaysian national diabetes registries to inform the healthcare stakeholders and policy makers on potential areas of clinical practice improvement and future researches. Under performance of the process measures and sub-optimal control of HbA1c, blood pressure and lipids profile were prevalent (<40% achieved treatment targets). Although these had improved slightly from 2009 to 2012, diabetes co-morbidities (hypertension and dyslipidaemia) and complications had also increased. Prevalence of insulin use had doubled, and lipid lowering agent use had increased about 50% in 2012 compared to 2009. We identified six clinical areas for urgent attention and improvement, and three potential areas for future research.

Keywords: Blood pressure; Diabetes complications; HbA1c; Lipids; Registries; Treatment; Type 2 diabetes mellitus.

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use
  • Biomarkers / blood
  • Blood Pressure
  • Comorbidity
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / epidemiology
  • Dyslipidemias / blood
  • Dyslipidemias / drug therapy
  • Dyslipidemias / epidemiology
  • Female
  • Glycated Hemoglobin / metabolism
  • Guideline Adherence
  • Health Facilities*
  • Health Priorities
  • Humans
  • Hypertension / drug therapy
  • Hypertension / epidemiology
  • Hypertension / physiopathology
  • Hypoglycemic Agents / therapeutic use*
  • Hypolipidemic Agents / therapeutic use
  • Lipids / blood
  • Malaysia / epidemiology
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Public Health*
  • Registries
  • Risk Factors
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Biomarkers
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Lipids
  • hemoglobin A1c protein, human